XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Oct. 31, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Allocated Share-based compensation expense disclosure
The impact on our results for share-based compensation was as follows:

Years Ended October 31,
202220212020
(in millions)
Cost of products and services$30 $26 $21 
Research and development14 12 
Selling, general and administrative82 73 54 
Total share-based compensation expense$126 $111 $84 
Share-based compensation arrangement by share-based payment award fair value assumptions and methodology schedule
The following assumptions were used to estimate the fair value of awards granted.

 Years Ended October 31,
 202220212020
Stock Option Plan:
Weighted average risk-free interest rate1.5%0.5%
Dividend yield0.5%0.7%
Weighted average volatility26%26%
Expected life5.5 years5.5 years
LTPP:   
Volatility of Agilent shares29%30%23%
Volatility of selected peer-company shares
23%-81%
24%-57%
15%-44%
Pair-wise correlation with selected peers41%45%29%
Post-vest restriction discount for all executive awards6.5%6.8%5.3%
Summary of stock option award activity
The following table summarizes employee stock option award activity of our employees and directors for 2022.

Options
Outstanding
Weighted
Average
Exercise Price
 (in thousands) 
Outstanding at October 31, 2021943 $69 
Granted279 $158 
Exercised(108)$38 
Cancelled(17)$130 
Outstanding at October 31, 20221,097 $94 
Schedule of share-based compensation, shares authorized under stock option plans, by exercise price range
The options outstanding and exercisable for equity share-based payment awards at October 31, 2022 were as follows:

 Options OutstandingOptions Exercisable
Range of
Exercise Prices
Number
Outstanding
Weighted
Average
Remaining
Contractual
Life
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
Number
Exercisable
Weighted
Average
Remaining
Contractual
Life
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
 (in thousands)(in years) (in thousands)(in thousands)(in years) (in thousands)
$25.00 - $40.00
69 1.0$38 $6,958 69 1.0$38 $6,958 
$40.01 - $50.00
386 2.0$41 37,556 386 2.0$41 37,556 
$100.00- $110.00
325 8.0$110 9,254 90 8.0$110 2,555 
$110.01 - $150.00
65 8.9$128 687 8.5$127 99 
$150.01 & Over
252 9.0$161 — 9.0$159 — 
1,097 5.8$94 $54,455 560 3.1$54 $47,168 
Schedule of intrinsic value of options exercised and the fair value of options granted
The following table summarizes the aggregate intrinsic value of options exercised in 2022, 2021 and 2020 and the fair value of options granted in 2022:

Aggregate
Intrinsic Value
Weighted
Average
Exercise
Price
Per Share Value Using Black-Scholes Model
 (in thousands) 
Options exercised in fiscal 2020$30,481 $34 
Options exercised in fiscal 2021$34,305 $33 
Black Scholes per share value of options granted during fiscal 2021$26 
Options exercised in fiscal 2022$10,765 $38 
Black Scholes per share value of options granted during fiscal 2022$39 
Non-vested award activity disclosure
The following table summarizes non-vested award activity in 2022 primarily for our LTPP and restricted stock unit awards.
SharesWeighted
Average
Grant Price
 (in thousands) 
Non-vested at October 31, 20212,519 $88 
Granted696 $155 
Vested(1,189)$75 
Forfeited(112)$114 
Change in LTPP shares in the year due to exceeding performance targets189 $65 
Non-vested at October 31, 20222,103 $114